NIPER Develops a New Drug For Type II Diabetes
The National Institute of Pharmaceutical Education and Research, Ahmedabad (NIPER-A), claims to have developed a new class of compounds for […]
Say something
Tags: ahmedabad, Association of Commonwealth Universities, chemical molecules, diabetes, Director, education, health, Health/Medical/Pharmaceuticals, India, Kiran Kalia, manufacturing, manufacturing process, MB Institute of Mental Health, medicine, mohali, MS, National Institute of Pharmaceutical Education, National Institute of Pharmaceutical Education and Research, Patent Filing, Rifampicin, strain, TB, tuberculosis, Type-II diabetes
Sanofi to produce synthetic antimilarial drugs
French drug maker Sanofi has announced the launch of a new commercial-scale manufacturing process to develop tons of artemisinin, the […]
Aravind Eye Hospital’s new to Contact lenses manufacturing unit
Aravind Eye Hospital’s Aurolab which produces Intra Ocular lens (IOL) and other surgical instruments, is set to get a new manufacturing facility in 1,10,000 sq ft area at Veerapanchan in Tamil Nadu.
-
-
Flipkart Health+ App Launched
06-04-2022
